Safety and efficacy of ipilimumab in melanoma patients who received prior immunotherapy on phase III study MDX010-020.
暂无分享，去创建一个
W. Urba | H. Kaufman | D. McDermott | J. Lutzky | Joseph I. Clark | A. Pecora | F. Collichio | K. Margolin | D. Lawson | A. Amin | K. Bennett